Literature DB >> 9129208

Immunophenotypic and functional characterization of human tonsillar mast cells.

W Füreder1, H C Bankl, J Toth, S Walchshofer, W Sperr, H Agis, H Semper, C Sillaber, K Lechner, P Valent.   

Abstract

Mast cells (MC) are proinflammatory immune cells residing in various organs. Tissue-specific heterogeneity of MC has been described. The aim of this study was to establish the phenotype and functional profile of human tonsillar mast cells (ToMC) and to compare ToMC with lung-, skin-, and uterus MC. Tonsillar tissue was obtained from 23 patients suffering from hyperplastic tonsils and dispersed by enzymatic digestion. With the use of a combined toluidine blue/immunofluorescence staining technique, isolated ToMC were found to react with monoclonal antibodies (mAb) to immunoglobulin E, CD9, CD43, CD44, CD46, CD54, CD55, and CD59, as well as mAb to stem cell factor (SCF) receptor (CD117/c-kit). ToMC were not recognized by mAb to other cytokine receptors or mAb to CD3, CD11b, CD14, CDw17, the skin MC marker CD88 (C5aR) or CD89 (Fc alphaR). Activation of ToMC by recombinant human (rh) SCF or anti-IgE resulted in histamine secretion, whereas no effects were seen with rhC5a, rh granulocyte-macrophage colony-stimulating factor, or rh interleukin-1 through -10. In summary, ToMC exhibit functional and phenotypic properties similar to lung- or uterus MC. Unlike skin MC, ToMC lack C5aR and are unresponsive to rhC5a.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9129208     DOI: 10.1002/jlb.61.5.592

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  7 in total

1.  Enhancement of antibody-dependent cell-mediated cytotoxicity by endowing IgG with FcαRI (CD89) binding.

Authors:  M Jack Borrok; Nadia M Luheshi; Nurten Beyaz; Gareth C Davies; James W Legg; Herren Wu; William F Dall'Acqua; Ping Tsui
Journal:  MAbs       Date:  2015       Impact factor: 5.857

Review 2.  Deciphering the differentiation trajectory from hematopoietic stem cells to mast cells.

Authors:  Jennine Grootens; Johanna S Ungerstedt; Gunnar Nilsson; Joakim S Dahlin
Journal:  Blood Adv       Date:  2018-09-11

3.  KIT signaling is dispensable for human mast cell progenitor development.

Authors:  Joakim S Dahlin; Maria Ekoff; Jennine Grootens; Liza Löf; Rose-Marie Amini; Hans Hagberg; Johanna S Ungerstedt; Ulla Olsson-Strömberg; Gunnar Nilsson
Journal:  Blood       Date:  2017-08-08       Impact factor: 22.113

4.  Tetraspanins in mast cells.

Authors:  Martin Köberle; Susanne Kaesler; Wolfgang Kempf; Florian Wölbing; Tilo Biedermann
Journal:  Front Immunol       Date:  2012-05-07       Impact factor: 7.561

Review 5.  Tetraspanins in the regulation of mast cell function.

Authors:  Zane Orinska; Philipp M Hagemann; Ivana Halova; Petr Draber
Journal:  Med Microbiol Immunol       Date:  2020-06-07       Impact factor: 3.402

6.  Generation of mast cells from mouse fetus: analysis of differentiation and functionality, and transcriptome profiling using next generation sequencer.

Authors:  Nobuyuki Fukuishi; Yuusuke Igawa; Tomoyo Kunimi; Hirofumi Hamano; Masao Toyota; Hironobu Takahashi; Hiromichi Kenmoku; Yasuyuki Yagi; Nobuaki Matsui; Masaaki Akagi
Journal:  PLoS One       Date:  2013-04-03       Impact factor: 3.240

7.  Interleukin-3 does not affect the differentiation of mast cells derived from human bone marrow progenitors.

Authors:  Yuji Shimizu; Kenji Matsumoto; Yoshimichi Okayama; Kentaro Sakai; Toshitaka Maeno; Tatsuo Suga; Toru Miura; Shinji Takai; Masahiko Kurabayashi; Hirohisa Saito
Journal:  Immunol Invest       Date:  2008       Impact factor: 3.657

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.